![Retail investors wait at NH Investment & Securities’ headquarters in Yeouido, western Seoul, last week, to place orders for shares in the public offering of SK Bioscience. [SK BIOSCIENCE]](https://image.koreajoongangdaily.com/11680041.webp?imageId=11680041&width=960&height=642&format=jpg)
SK Bioscience started trading on the local stock market Thursday with a starting price of 130,000 won ($116), double the subscription price of 65,000 won.
A starting price is set at between 90 percent and 200 percent of a company's public subscription price based on bid and ask prices before the market's opening on the first day of trading.
SK Bioscience's starting price was what brokerages expected.
As of 9:02 a.m. the company's shares reached the gain ceiling of 30 percent, or 169,000 won, raising the company's market capitalization to 12.9 trillion won.
The Covid-19 vaccine maker started trading as one of the stocks that makes up the main Kospi index.
BY KIM JEE-HEE [kim.jeehee@joongang.co.kr]
